Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00546884 · ClinicalTrials.gov registry record · NA
Intervention to Improve Expression of End of Life Preferences for Homeless Persons
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 262
- Enrollment target
NCT00546884: Completed NA study, sponsored by University of Minnesota.
NCT00546884 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 262 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00546884, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether homeless individuals will complete a living will and whether guidance enhances rates of completion and to see whether filling out a living will has any impact on the care given at the end of life.
Primary Outcome
Completing an advance directive for the individuals health care when they are not able to direct it themselves
Interventions
- BEHAVIORAL MI condition
- BEHAVIORAL GI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-07 |
| Phase | NA |
What the finished NCT00546884 record still lists
NCT00546884 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which MI condition is the first listed.
NCT00546884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00546884 about?
NCT00546884 is a clinical study titled "Intervention to Improve Expression of End of Life Preferences for Homeless Persons". The purpose of this study is to determine whether homeless individuals will complete a living will and whether guidance enhances rates of completion and to see whether filling out a living will has any impact on the care given at the end of life.
What is the current status of trial NCT00546884?
This trial is currently completed. It is a NA study. The enrollment target is 262 participants. The study started on 2007-11. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00546884?
The interventions under investigation include: MI condition (BEHAVIORAL), GI (BEHAVIORAL).
Who is sponsoring clinical trial NCT00546884?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00546884's enrollment target sits among peer trials
262 397th of 2000 higher than 1,604 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06293703 · 262 participants · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia